Mill Creek Capital Advisors, LLC Gilead Sciences, Inc. Transaction History
Mill Creek Capital Advisors, LLC
- $4.09 Billion
- Q3 2024
A detailed history of Mill Creek Capital Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mill Creek Capital Advisors, LLC holds 2,768 shares of GILD stock, worth $249,645. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,768
Previous 2,993
7.52%
Holding current value
$249,645
Previous $205,000
13.17%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
1,923Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.4 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.9 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.57 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.43 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $113B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...